1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61:69-90. | | 2. Cancer of female breast (IUD 9: 174). In: National Cancer Registry programme, Biennial report: An epidemiological study. New Delhi, ICMR: 1988-89; 27-4. | | 3. Carlos A, Perez CA, Taylor ME. Breast: Stage Tis, T1 and T2 tumors. In: Perez CA, ed. Principles and practice of radiation oncology. Philadelphia: Lippincott - Raven, 1999;1269-1396. | | 4. McWhirter R. Simple mastectomy and radiotherapy in the treatment of breast cancer. Brit J Radiol. 1955; 28:128-139 [DOI via Crossref] [Pubmed] | | 5. Magee B, Ribeiro GG, Williams P, Swindell R. Use of an electron beam for post mastectomy radiotherapy. Clinic Oncol. 1991; 3: 310-314. [DOI via Crossref] | | 6. Fletcher GH. Local results of irradiation in the primary management of localised breast cancer. Cancer. 1972; 5:545-551 [DOI via Crossref] | | 7. Brown GR, Horiot JC, Fletcher GH, White EC, Ange DW. Simple mastectomy and radiation therapy for locally advanced breast cancers technically suitable for radical mastectomy. Am J Roent. 1974; 120: 67-73. [DOI via Crossref] | | 8. Archambault M, Griem ML, Loch¬man DJ. Results of ultrafraction radiation therapy in breast carcinoma. Am J Roent. 1964; 91:61-66 | | 9. Danish Breast Cancer Cooperative Group, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24(15):2268-75. [DOI via Crossref] [Pubmed] | | 10. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link.Radiother Oncol. 2000;55(3):263-72. [DOI via Crossref] | | 11. Vin-Hungh V, Verschraegen C. The Breast Conserving Surgery Project Breast-conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumour recurrence and mortality. J Natl Cancer Inst. 2004;96:115-21. [DOI via Crossref] | | 12. Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA et al. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.Int J Radiat Oncol Biol Phys. 2009;73(4):997-1002. [DOI via Crossref] [Pubmed] | | 13. Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med. 2009, 360:63-70. | | 14. Gold HT, Do HT, Dick AW. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer. 2008, 113:3108-3115 | | 15. Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer. 2008, 44:992-999. | | 16. Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Wait times for surgical and adjuvant radiation treatment of breast cancer in Canada and the United States: greater socioeconomic inequity in America. Clin Invest Med. 2009, 32:E239-E249 | | 17. Gebski V, Lagleva M, Keech A, Simes J, Langlands AO. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst. 2006, 98:26-38. | | 18. Kaufmann M, Morrow M, Von Minckwitz G, Harris JR. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer. 2010, 116:1184-1191 | | 19. Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons.Breast Cancer Res Treat. 2010;124:141-151. [DOI via Crossref] [Pubmed] | | 20. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91-102. [DOI via Crossref] | | 21. Beitsch PD, Shaitelman SF, Vicini FA. Accelerated partial breast irradiation. J Surg Oncol. 2011; 103:362-368. [DOI via Crossref] [Pubmed] | | 22. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hardenbergh PH, Julian TB. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys. 2009;74:987-1001. | | 23. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513-520. [DOI via Crossref] [Pubmed] | | 24. Bonadonna G. Systemic treatment of breast cancer. N Engl J Med. 19811304:10-12. | | 25. Miller AB. WHO grading of toxicity. Cancer. 1981;47:207-214 [DOI via Crossref] | | 26. Will BP, LePetit C, Berthelot JM, Tomiak EM, Verma S. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs. Br J Cancer. 1999;79,1428-1436 | | 27. Baker RR. The clinical management of primary breast cancer. In Baker RR, ed. Current trends in management of breast cancer. Baltimore: Cassell and Collier Macmillian, 1977;77-123 | | 28. Chapman JW, Fish EB, Link MA. Competing risks analyses for recur-rence from primary breast cancer. Br J Cancer. 1999;79:1508-1513 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 29. Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;47:1219-1228. [DOI via Crossref] | | 30. Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CM, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996; 41:7-13 [DOI via Crossref] | | 31. Yarnold J, Bentzen SM, Coles C, Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys. 2011;79: 1-9 [DOI via Crossref] [Pubmed] | | 32. Taher AN, El-Baradie MM, Essa H, Zaki O, Ezzat S, et al. Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Natl Canc Inst. 2004;16: 178-187. | | 33. Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995;31: 1171-1185. [DOI via Crossref] | | 34. Awwad HK. Dose-Time-Volume relationships in normal tissue to radiation. In Radiation Oncology: Radiobiological and Physiological Prespective. Kluwer Academic, Dordecht, Boston, London. 1990; 129-187 | | 35. Deantonio L, Gambaro G, Beldì D, Masini L, Tunesi S, et al. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Radiat Oncol. 2010;5: 112 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 36. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7: 467-471. [DOI via Crossref] | | 37. Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, et al. A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thai. 2011;94: S94-S102. | |
|
|